Pegylated Interferon Alpha2b

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
227	オスラー病	1

227. オスラー病

臨床試験数 : 56 / 薬物数 : 72 - (DrugBank : 21) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 136

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00588146 (ClinicalTrials.gov)	January 2007	26/12/2007	Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia	Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia	Anemia;Liver Disease;Hypoxemia	Drug: Pegylated Interferon Alpha2b;Other: Standard care	Mayo Clinic	Augusta University;St. Michael's Hospital, Toronto;Schering-Plough	Terminated	18 Years	70 Years	All	10	Phase 2	United States

First Previous1Next Last